| Status: In progress | |
Adjunctive therapy in the treatment of partial-onset seizures with or without secondary generalisation in children from 2 years to < 4 years of age with epilepsy. |
|
Medicine details |
|
| Medicine name | brivaracetam (Briviact®) |
| Formulation | 10 mg, 25 mg, 50 mg, 75 mg, 100 mg film-coated tablets; 10 mg/ml oral solution; 10 mg/ml solution for injection/infusion |
| Reference number | 4614 |
| Indication | As above |
| Company | UCB Pharma Ltd |
| BNF chapter | Central nervous system |
| Submission type | Licence extension for paediatric use |
| Status | In progress |
| AWMSG meeting date | TBC |
| Date of issue | TBC |